Summit Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.25M | Buy |
4,983
+73
| +1% | +$15.7K | 0.16% | 66 |
|
|
2026
Q1 | $1.07M | Buy |
4,910
+1
| +0% | +$222 | 0.15% | 73 |
|
|
2025
Q4 | $1.12M | Buy |
4,909
+51
| +1% | +$11.6K | 0.16% | 65 |
|
|
2025
Q3 | $1.12M | Buy |
4,858
+1
| +0% | +$204 | 0.17% | 65 |
|
|
2025
Q2 | $902K | Buy |
4,857
+29
| +0.6% | +$5.39K | 0.15% | 74 |
|
|
2025
Q1 | $1.01M | Buy |
4,828
+1
| +0% | +$194 | 0.18% | 68 |
|
|
2024
Q4 | $858K | Buy |
4,827
+1
| +0% | +$184 | 0.15% | 76 |
|
|
2024
Q3 | $953K | Buy |
4,826
+1
| +0% | +$187 | 0.18% | 65 |
|
|
2024
Q2 | $828K | Sell |
4,825
-84
| -2% | -$13.9K | 0.17% | 68 |
|
|
2024
Q1 | $894K | Buy |
4,909
+2
| +0% | +$345 | 0.19% | 59 |
|
|
2023
Q4 | $761K | Buy |
4,907
+528
| +12% | +$77K | 0.18% | 63 |
|
|
2023
Q3 | $653K | Buy |
4,379
+1
| +0% | +$147 | 0.18% | 66 |
|
|
2023
Q2 | $590K | Sell |
4,378
-51
| -1% | -$7.48K | 0.16% | 73 |
|
|
2023
Q1 | $706K | Buy |
4,429
+102
| +2% | +$15.6K | 0.19% | 59 |
|
|
2022
Q4 | $699K | Buy |
4,327
+2
| +0% | +$307 | 0.2% | 63 |
|
|
2022
Q3 | $581K | Buy |
4,325
+1
| +0% | +$143 | 0.19% | 68 |
|
|
2022
Q2 | $662K | Sell |
4,324
-135
| -3% | -$20.6K | 0.2% | 63 |
|
|
2022
Q1 | $723K | Buy |
4,459
+259
| +6% | +$37.6K | 0.21% | 67 |
|
|
2021
Q4 | $569K | Buy |
4,200
+337
| +9% | +$39.8K | 0.16% | 79 |
|
|
2021
Q3 | $417K | Sell |
3,863
-382
| -9% | -$43.6K | 0.13% | 95 |
|
|
2021
Q2 | $478K | Buy |
4,245
+392
| +10% | +$44.1K | 0.15% | 79 |
|
|
2021
Q1 | $417K | Sell |
3,853
-490
| -11% | -$52.4K | 0.14% | 90 |
|
|
2020
Q4 | $465K | Buy |
4,343
+509
| +13% | +$48.9K | 0.17% | 76 |
|
|
2020
Q3 | $336K | Buy |
3,834
+609
| +19% | +$57.3K | 0.14% | 88 |
|
|
2020
Q2 | $317K | Buy |
+3,225
| New | +$284K | 0.14% | 86 |
|
|
2020
Q1 | – | Sell |
-2,523
| Closed | -$223K | – | 111 |
|
|
2019
Q4 | $223K | Buy |
+2,523
| New | +$209K | 0.1% | 108 |
|
|
2019
Q1 | – | Sell |
-2,434
| Closed | -$224K | – | 112 |
|
|
2018
Q4 | $224K | Buy |
2,434
+13
| +0.5% | +$1.14K | 0.13% | 91 |
|
|
2018
Q3 | $229K | Buy |
2,421
+12
| +0.5% | +$1.14K | 0.11% | 101 |
|
|
2018
Q2 | $223K | Buy |
2,409
+11
| +0.5% | +$1.07K | 0.11% | 100 |
|
|
2018
Q1 | $227K | Buy |
2,398
+7
| +0.3% | +$769 | 0.11% | 98 |
|
|
2017
Q4 | $231K | Sell |
2,391
-149
| -6% | -$14K | 0.11% | 100 |
|
|
2017
Q3 | $226K | Buy |
+2,540
| New | +$193K | 0.11% | 98 |
|
|
2015
Q2 | – | Sell |
-3,988
| Closed | -$233K | – | 94 |
|
|
2015
Q1 | $233K | Buy |
3,988
+9
| +0.2% | +$544 | 0.16% | 83 |
|
|
2014
Q4 | $260K | Buy |
3,979
+7
| +0.2% | +$441 | 0.19% | 76 |
|
|
2014
Q3 | $229K | Sell |
3,972
-1,237
| -24% | -$68.7K | 0.18% | 75 |
|
|
2014
Q2 | $294K | Buy |
5,209
+9
| +0.2% | +$472 | 0.23% | 67 |
|
|
2014
Q1 | $267K | Buy |
5,200
+8
| +0.2% | +$404 | 0.21% | 71 |
|
|
2013
Q4 | $274K | Sell |
5,192
-200
| -4% | -$9.83K | 0.22% | 67 |
|
|
2013
Q3 | $241K | Buy |
5,392
+200
| +4% | +$8.87K | 0.21% | 72 |
|
|
2013
Q2 | $215K | Buy |
+5,192
| New | +$227K | 0.21% | 73 |
|
Other funds holding ABBV
Summit Asset Management's ABBV Position: Q2 2026 in Review
Summit Asset Management increased its AbbVie (ABBV) stake by 1.5% in Q2 2026, buying an estimated $15.7K and bringing the position to 4,983 shares worth $1.25M. The position accounts for 0.16% of the portfolio, ranked #66.
Summit Asset Management first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Summit Asset Management held 4,983 shares of AbbVie worth $1.25M as of Q2 2026.
- Summit Asset Management bought 73 AbbVie shares in Q2 2026, an estimated $15.7K.
- AbbVie made up 0.16% of Summit Asset Management's portfolio in Q2 2026, its #66 holding.
- Summit Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Summit Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.